This content is machine translated Cancer risk increased after heart transplantation New heart, new cancer? After heart transplantation, it is mandatory to suppress the immune system. There is a risk of rejection of the new organ. However, this also means that degenerated cells can no…
View Post 3 min This content is machine translated Annual Congress of the American Urological Association (AUA), San Francisco Risk assessment in prostate cancer: what do biomarkers do? Since the implementation of PSA testing, the number of PCa diagnoses has multiplied. Biomarkers are increasingly used to prevent overdiagnosis and overtreatment. New approaches, but also limitations, of microbiological testing…
View Post 4 min This content is machine translated European study Young oncologists are burned out and exhausted Burnout syndrome is ubiquitous in the medical world. The largest survey ever conducted on the subject raises eyebrows: Two-thirds of all young European oncologists show signs of burnout. What now?
View Post 7 min This content is machine translated ELCC 2018 in Geneva Not “only” live longer, but also better Atezolizumab enables long-term survival for some pretreated lung cancer patients. Alectinib also helps patients live a more tolerable daily life by mitigating disease symptoms over the longer term. These are…
View Post 13 min This content is machine translated Colorectal carcinoma Multimodal concepts for a curative therapeutic approach The treatment of colorectal carcinoma has improved greatly. Patients today benefit from multimodal therapeutic approaches even in advanced stages and metastases. Management must be interdisciplinary.
View Post 5 min This content is machine translated Gynecology Update Refresher Vulvar cancer – where do we stand today? Detection of precancerous lesions is important in light of rising incidence rates of vulvar cancer internationally. There is a need to catch up especially in the area of HPV-negative lesions.
View Post 1 min This content is machine translated Video advanced training St. Claraspital Gastroforum On the scene: further diagnostics and their consequences The diagnosis of pancreatic cysts and intraductal papillary mucinous neoplasia (IPMN) are the topics of the continuing education lecture by Dr. med. Matthias Sauter, Senior Consultant Gastroenterologist, St. Claraspital, Basel.
View Post 4 min This content is machine translated Microbiome as a predictive biomarker The intestine oracle The complexity of the human intestinal flora is increasingly better understood. The gut even seems to have an impact on who responds to cancer immunotherapy and who doesn’t. …
View Post 2 min This content is machine translated Groundbreaking research findings from Ticino The tumor likes “fat Future drugs could reduce fats in the cancer cell by inhibiting a specific, newly researched metabolic component. The tumor would be “starved out.” Results of a research group from Bellinzona.
View Post 3 min This content is machine translated Personalized therapy for lung tumors Has platinum-containing first-line therapy had its day? Personalized immunotherapy is on track to replace chemotherapy in first-line non-small cell lung cancer. However, this only works for every second patient. Chemo vs. immuno-oncology – who will win the…
View Post 6 min This content is machine translated Advanced training course in clinical oncology in St. Gallen New therapies in HR-positive metastatic breast cancer. In HR-positive metastatic breast cancer, there are several new treatment options. The aim of the annual oncology conference in St. Gallen was to classify and evaluate these substances. What might…
